|
17 Apr 2007 |
Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
|
|
17 Apr 2007 |
Regulatory Review Allows LCT Diabetes Clinical Program to Proceed
|
|
17 Apr 2007 |
Metabasis Therapeutics Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research
|
|
14 Apr 2007 |
Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275
|
|
14 Apr 2007 |
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
|
|
13 Apr 2007 |
MedImmune Explores Strategic Alternatives
|
|
13 Apr 2007 |
Intarcia Therapeutics Announces Final Results From A Phase 2 Study Of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
|
|
13 Apr 2007 |
Coley Pharmaceutical Group Licenses VaxImmune(TM) to Merck for Use in Vaccine Programs
|
|
13 Apr 2007 |
Ranbaxy Receives FDA Approval To Market Loratadine Antihistamine Tablets
|
|
13 Apr 2007 |
Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma
|
|
12 Apr 2007 |
Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases
|
|
12 Apr 2007 |
Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals
|
|
12 Apr 2007 |
Xanthus Acquires from Johns Hopkins University Exclusive License to Patent Estate Covering FLT3 Pathway as a Target for Treating Autoimmune Diseases
|
|
12 Apr 2007 |
Repligen Licenses Potential Treatment for Friedreich's Ataxia from The Scripps Research Institute
|
|
12 Apr 2007 |
TopoTarget enters into share purchase agreement for the acquisition of Apoxis SA and plans to raise new capital through an offer of new shares
|
|
11 Apr 2007 |
Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists
|
|
11 Apr 2007 |
Inhibitex Signs Definitive Agreement to Acquire FermaVir Pharmaceuticals
|
|
10 Apr 2007 |
Caliper Life Sciences to Explore Novel Indications for Drug Candidates
|
|
07 Apr 2007 |
Stratagene Signs Definitive Agreement to Be Acquired by Agilent Technologies
|
|
06 Apr 2007 |
JDRF To Collaborate with MediGene to Develop an Antigen-Specific Immunotherapeutic for Type I Diabetes
|
|
05 Apr 2007 |
pSivida signs A$203 million (US$165 million)
|
|
05 Apr 2007 |
pSivida signs A$203 million (US$165 million)
|
|
05 Apr 2007 |
AVEO enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO's Novel Anti-HGF Antibody
|
|
05 Apr 2007 |
Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
|
|
05 Apr 2007 |
CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus
|
